Mirae Asset Global Investments
TVTX icon

Mirae Asset Global Investments’s Travere Therapeutics TVTX Stock Holding History

Mirae Asset Global Investments’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$236K Sell
4,159
-652
-14% -$28.9K ﹤0.01% 1095
2026
Q1 		$143K Buy
4,811
+463
+11% +$13.8K ﹤0.01% 1129
2025
Q4 		$166K Buy
4,348
+902
+26% +$29.3K ﹤0.01% 1176
2025
Q3 		$82.4K Buy
3,446
+15
+0.4% +$282 ﹤0.01% 1257
2025
Q2 		$50.8K Buy
3,431
+462
+16% +$7.66K ﹤0.01% 1252
2025
Q1 		$58.4K Buy
2,969
+108
+4% +$2.19K ﹤0.01% 1211
2024
Q4 		$49.4K Buy
2,861
+94
+3% +$1.66K ﹤0.01% 1267
2024
Q3 		$38.8K Buy
2,767
+494
+22% +$5.15K ﹤0.01% 1345
2024
Q2 		$18.8K Sell
2,273
-47,905
-95% -$323K ﹤0.01% 1386
2024
Q1 		$804K Buy
50,178
+3,754
+8% +$31.7K ﹤0.01% 1651
2023
Q4 		$417K Buy
46,424
+3,083
+7% +$22.4K ﹤0.01% 2054
2023
Q3 		$387K Sell
43,341
-5,326
-11% -$75.2K ﹤0.01% 2011
2023
Q2 		$747K Buy
48,667
+4,767
+11% +$86.7K ﹤0.01% 1748
2023
Q1 		$987K Buy
43,900
+12,340
+39% +$262K ﹤0.01% 1556
2022
Q4 		$664K Buy
31,560
+28
+0.1% +$593 ﹤0.01% 1726
2022
Q3 		$777K Buy
31,532
+12,290
+64% +$318K ﹤0.01% 1623
2022
Q2 		$466K Buy
+19,242
New +$484K ﹤0.01% 1784

Other funds holding TVTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments's TVTX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Travere Therapeutics (TVTX) stake by 14% in Q2 2026, selling an estimated $28.9K and leaving 4,159 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #1095.

Mirae Asset Global Investments first reported a position in TVTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $987K in Q1 2023. 111 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Mirae Asset Global Investments held 4,159 shares of Travere Therapeutics worth $236K as of Q2 2026.
  • Mirae Asset Global Investments sold 652 Travere Therapeutics shares in Q2 2026, an estimated $28.9K.
  • Travere Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1095 holding.
  • Mirae Asset Global Investments first reported a position in Travere Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Travere Therapeutics position peaked at $987K in Q1 2023.
  • 111 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.